Upregulated ATF1 Promotes Lipopolysaccharide Induced Inflammatory Response and Inhibits Osteogenic Differentiation of Human Periodontal Ligament Cells by Regulating NF- κB Pathway

CONCLUSIONS: ATF1 emerges as a promising treatment option, inhibiting the osteogenic differentiation of hPDLCs and mitigating the inflammatory response by preventing the phosphorylation of the NF-κB signaling pathway.PMID:38531792 | DOI:10.24976/Discov.Med.202436182.48
Source: Discovery Medicine - Category: Research Authors: Source Type: research
More News: Research | Study